Why the study?
Do angiotensin II receptor antagonists improve tolerability and treatment compliance in hypertensive patients?
Population
Treated hypertensive patients
Design
Review
Authors
Loading...
Supports ARB tolerability emphasis in hypertension; leaves open whether this improves real-world compliance versus alternatives.
Do angiotensin II receptor antagonists improve tolerability and treatment compliance in hypertensive patients?
This review highlights the importance of treatment compliance in hypertension and discusses the favorable tolerability profile of angiotensin II receptor antagonists.
Giuseppe Mancia (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: